Jyong Biotech Ltd.’s Quiet Period Set To Expire on July 28th (NASDAQ:MENS)

Jyong Biotech’s (NASDAQ:MENS) quiet period will expire on Monday, July 28th. Jyong Biotech had issued 2,666,667 shares in its public offering on June 17th. The total size of the offering was $20,000,003 based on an initial share price of $7.50. During the company’s quiet period, insiders and any underwriters that worked on the IPO are prevented from issuing any research reports for the company because of SEC regulations. Following the end of the company’s quiet period, it’s expected that the brokerages that served as underwriters on the stock will initiate research coverage on the company.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen raised shares of Jyong Biotech to a “hold” rating in a research report on Monday, June 30th.

Jyong Biotech Stock Down 4.2%

NASDAQ:MENS opened at $10.55 on Monday. Jyong Biotech has a 52 week low of $6.01 and a 52 week high of $19.99.

About Jyong Biotech

OUR MISSION We endeavor to develop and supply first-class innovative drugs to meet our customers’ health needs. We seek to be a valuable business organization that is held in high esteem by the public. We are a science-driven biotechnology company based in Taiwan and are committed to developing and commercializing innovative and differentiated new drugs (plant-derived) mainly specializing in the treatment of urinary system diseases, with an initial focus on the markets of the U.S., the EU, and Asia.